93 related articles for article (PubMed ID: 25302595)
1. [Molecular approaches to systemic therapy of adenoid cystic carcinoma of the head and neck area].
Büchsenschütz K; Veit JA; Schuler PJ; Thierauf J; Laban S; Fahimi F; Bankfalvi A; Lang S; Sauerwein W; Hoffmann TK
Laryngorhinootologie; 2014 Oct; 93(10):657-64. PubMed ID: 25302595
[TBL] [Abstract][Full Text] [Related]
2. [Systemic treatments of metastatic or locally recurrent adenoid cystic carcinoma of the head and neck, a systematic review].
Cherifi F; Rambeau A; Johnson A; Florescu C; Géry B; Babin E; Thariat J
Bull Cancer; 2019 Oct; 106(10):923-938. PubMed ID: 31324333
[TBL] [Abstract][Full Text] [Related]
3. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.
Dodd RL; Slevin NJ
Oral Oncol; 2006 Sep; 42(8):759-69. PubMed ID: 16757203
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapies.
Ross JS; Wang K; Rand JV; Sheehan CE; Jennings TA; Al-Rohil RN; Otto GA; Curran JC; Palmer G; Downing SR; Yelensky R; Lipson D; Balasubramanian S; Garcia L; Mahoney K; Ali SM; Miller VA; Stephens PJ
Am J Surg Pathol; 2014 Feb; 38(2):235-8. PubMed ID: 24418857
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: a review.
Papaspyrou G; Hoch S; Rinaldo A; Rodrigo JP; Takes RP; van Herpen C; Werner JA; Ferlito A
Head Neck; 2011 Jun; 33(6):905-11. PubMed ID: 20652885
[TBL] [Abstract][Full Text] [Related]
6. As2O3 may be a treatment option for adenoid cystic carcinoma of salivary gland.
Fu ZC; Zhang B; Fu ZJ
Med Hypotheses; 2010 Dec; 75(6):490-1. PubMed ID: 20656411
[TBL] [Abstract][Full Text] [Related]
7. Adenoid cystic carcinoma of the head and neck: a single-center analysis of 105 consecutive cases over a 30-year period.
van Weert S; Bloemena E; van der Waal I; de Bree R; Rietveld DH; Kuik JD; Leemans CR
Oral Oncol; 2013 Aug; 49(8):824-9. PubMed ID: 23751614
[TBL] [Abstract][Full Text] [Related]
8. Systemic and Targeted Therapies in Adenoid Cystic Carcinoma.
Kacew AJ; Hanna GJ
Curr Treat Options Oncol; 2023 Jan; 24(1):45-60. PubMed ID: 36637743
[TBL] [Abstract][Full Text] [Related]
9. Role of chemotherapy and molecularly targeted agents in the treatment of adenoid cystic carcinoma of the lacrimal gland.
Le Tourneau C; Razak AR; Levy C; Calugaru V; Galatoire O; Dendale R; Desjardins L; Gan HK
Br J Ophthalmol; 2011 Nov; 95(11):1483-9. PubMed ID: 21183517
[TBL] [Abstract][Full Text] [Related]
10. Adenoid cystic carcinoma of salivary and lacrimal gland origin: localization, classification, clinical pathological correlation, treatment results and long-term follow-up control in 84 patients.
Friedrich RE; Bleckmann V
Anticancer Res; 2003; 23(2A):931-40. PubMed ID: 12820326
[TBL] [Abstract][Full Text] [Related]
11. Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study.
Hotte SJ; Winquist EW; Lamont E; MacKenzie M; Vokes E; Chen EX; Brown S; Pond GR; Murgo A; Siu LL
J Clin Oncol; 2005 Jan; 23(3):585-90. PubMed ID: 15659505
[TBL] [Abstract][Full Text] [Related]
12. Head and neck adenoid cystic carcinoma: what is new in biological markers and treatment?
Bell D; Hanna EY
Curr Opin Otolaryngol Head Neck Surg; 2013 Apr; 21(2):124-9. PubMed ID: 23222122
[TBL] [Abstract][Full Text] [Related]
13. Microdissection genotyping analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma.
Tse DT; Finkelstein SD; Benedetto P; Dubovy S; Schiffman J; Feuer WJ
Am J Ophthalmol; 2006 Jan; 141(1):54-61. PubMed ID: 16386976
[TBL] [Abstract][Full Text] [Related]
14. Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment.
Münter MW; Schulz-Ertner D; Hof H; Nikoghosyan A; Jensen A; Nill S; Huber P; Debus J
Radiat Oncol; 2006 Jun; 1():17. PubMed ID: 16756669
[TBL] [Abstract][Full Text] [Related]
15. Systemic therapy in the management of metastatic or advanced salivary gland cancers.
Lagha A; Chraiet N; Ayadi M; Krimi S; Allani B; Rifi H; Raies H; Mezlini A
Oral Oncol; 2012 Oct; 48(10):948-957. PubMed ID: 22698431
[TBL] [Abstract][Full Text] [Related]
16. [Long term results in adenoidcystic carcinoma].
Issing PR; Hemmanouil I; Wilkens L; Karstens H; Lenarz T
Laryngorhinootologie; 2002 Feb; 81(2):98-105. PubMed ID: 11914946
[TBL] [Abstract][Full Text] [Related]
17. Large scale molecular analysis identifies genes with altered expression in salivary adenoid cystic carcinoma.
Frierson HF; El-Naggar AK; Welsh JB; Sapinoso LM; Su AI; Cheng J; Saku T; Moskaluk CA; Hampton GM
Am J Pathol; 2002 Oct; 161(4):1315-23. PubMed ID: 12368205
[TBL] [Abstract][Full Text] [Related]
18. Effects of imatinib mesylate on adenoid cystic carcinomas.
Ochel HJ; Gademann G; Röcken C; Wördehoff H
Anticancer Res; 2005; 25(5):3659-64. PubMed ID: 16101197
[TBL] [Abstract][Full Text] [Related]
19. Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection.
Oplatek A; Ozer E; Agrawal A; Bapna S; Schuller DE
Laryngoscope; 2010 Jan; 120(1):65-70. PubMed ID: 19877226
[TBL] [Abstract][Full Text] [Related]
20. Intraoral adenoid cystic carcinoma: is the presence of perineural invasion associated with the size of the primary tumour, local extension, surgical margins, distant metastases, and outcome?
Lukšić I; Suton P; Macan D; Dinjar K
Br J Oral Maxillofac Surg; 2014 Mar; 52(3):214-8. PubMed ID: 24325947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
